Production ramp-up is a challenge, chief executive says: ‘If one ingredient is missing, we cannot make a vaccine’
Moderna Inc. MRNA -4.03% Chief Executive Stéphane Bancel said the federal government could authorize emergency use of the company’s experimental Covid-19 vaccine in December, if the company gets positive interim results in November from a large clinical trial.
Mr. Bancel, speaking during The Wall Street Journal’s annual Tech Live conference Monday, said if sufficient interim results from the study takes longer to get, government authorization of the vaccine may not occur until early next year.
Cambridge, Mass.,-based Moderna has one of the leading Covid-19 vaccines in development, along with a vaccine co-developed by Pfizer Inc. PFE -0.40% and BioNTech SE. BNTX -0.18% Large U.S. trials for two other leading Covid-19 vaccines, from Johnson & Johnson and AstraZeneca PLC, have been paused, while the companies investigate unexplained illnesses among study subjects.
Mr. Bancel’s comments suggest Moderna’s timetable isn’t far off from Pfizer’s, which said last week it expects to seek U.S. authorization of emergency use of its vaccine by late November.
In July, Moderna started a 30,000-person study in the U.S. to test whether the vaccine safely protects people from symptomatic Covid-19 disease, and enrollment is nearly complete.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE